Drug or treatment

Crizotinib clinical trials

As of November 12, 2026, Find a Trial lists 3 clinical trials of Crizotinib that are recruiting, at sites in 3 countries (most in United States (2), China (1), Canada (1)). By phase: Phase 3 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Adjuvant darovasertib and crizotinib in high-risk non-metastatic uveal melanoma Phase 3 Scottsdale, Arizona and 12 other locations Recruiting Sep 4, 2026
Comparing Taletrectinib with Standard Therapy for ROS1 Positive Lung Cancer Phase 3 Hefei, Anhui and 28 other locations Recruiting Aug 21, 2024
Combining talazoparib with palbociclib, axitinib, or crizotinib for advanced solid tumors Phase 1 Houston, Texas Recruiting Jan 5, 2021

All recruiting trials (3)

Quick answers

How many clinical trials of Crizotinib are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (2 trials), China (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.